George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerro-alloy Re. Regulatory News (FAR)

Share Price Information for Ferro-alloy Re. (FAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.85
Bid: 4.70
Ask: 5.00
Change: -0.10 (-2.02%)
Spread: 0.30 (6.383%)
Open: 4.85
High: 4.85
Low: 4.85
Prev. Close: 4.95
FAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of 3rd Tranche of Exempt Offer Bond Programme

15 Feb 2024 13:00

RNS Number : 3148D
Ferro-Alloy Resources Limited
15 February 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 (INCLUDING AS IT FORMS PART OF THE LAWS OF ENGLAND AND WALES BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR").

 

15 February 2024

Ferro-Alloy Resources Limited

("Ferro-Alloy" or the "Group" or the "Company")

 

Sale of Third Tranche of Exempt Offer Bond Programme

 

Ferro-Alloy Resources Limited (LSE:FAR), the vanadium producer and developer of the large Balasausqandiq vanadium deposit in Southern Kazakhstan, is pleased to announce the sale of all bonds issued under the US$5m third tranche (the "Third Tranche") of the Kazakhstan exempt offer bond programme (the "Programme").

 

Background

As previously announced, the Company listed the Third Tranche of bonds under the Programme on 30 January 2024, for the development of the Balasausqandiq project including front-end engineering.

 

The nominal value of the Third Tranche was US$5m, with a nominal coupon rate of 11%, payable quarterly, and a two and a half year maturity.

 

Sale / Proceeds

All bonds listed under the Third Tranche have been sold and net proceeds of US$4.73m have now been received by the Company.

Summary

The three tranches of bonds issued and listed under the Programme to date have been sold, in aggregate, for US$13m. Under the terms of the Programme, US$7m of headroom remains for the issue of future tranches by the Company.

 

For further information, visit www.ferro-alloy.com or contact:

 

Ferro-Alloy Resources Limited

Nick Bridgen (CEO) / William Callewaert (CFO)

info@ferro-alloy.com

 

Freedom Finance Global PLC

(Bond Underwriter)

 

Renat Syzdykov

+7 701 766 4865 / ib@ffin.kz

Shore Capital 

(Joint Corporate Broker)

 

Liberum Capital Limited

(Joint Corporate Broker)

Toby Gibbs/Lucy Bowden

 

 

Scott Mathieson/John More

 

+44 207 408 4090

 

 

+44 20 3100 2000

 

St Brides Partners Limited

(Financial PR & IR Adviser)

Ana Ribeiro/Zoe Briggs

+44 207 236 1177

 

About Ferro-Alloy Resources Limited:

The Company's operations are all located at the Balasausqandiq deposit in Kyzylordinskoye Oblast in the South of Kazakhstan. Currently the Company has two main business activities:

a) the high grade Balasausqandiq vanadium project (the "Project"); and

b) an existing vanadium concentrate processing operation (the "Existing Operation")

Balasausqandiq is a very large deposit, with vanadium as the principal product together with several by-products. Owing to the nature of the ore, the capital and operating costs of development are very much lower than for other vanadium projects.

The most recent mineral resource estimate for ore-body one (of seven) provided an Indicated Mineral Resource of 32.9 million tonnes at a mean grade of 0.62% V2O5 equating to 203,364 contained tonnes of vanadium pentoxide ("V2O5"). In the system of reserve estimation used in Kazakhstan the reserves are estimated to be over 70m tonnes in ore-bodies 1 to 5 but this does not include the full depth of ore-bodies 2 to 5 or the remaining ore-bodies which remain substantially unexplored. 

The Project will be developed in two stages, Stage 1 and Stage 2, treating 1m tonnes per year and an additional 3m tonnes per year. Production will be some 5,600 tonnes of V2O5 from Stage 1, rising to 22,400 tonnes V2O5 after Stage 2 is commissioned.

There is an existing concentrate processing operation at the site of the Balasausqandiq deposit. The production facilities were originally created from a 15,000 tonnes per year pilot plant which was then expanded and adapted to recover vanadium, molybdenum and nickel from purchased concentrates. 

The existing operation is located on the same site and uses some of the same infrastructure as the Project, but is a separate operation which will continue in parallel with the development and operation of the Project.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISDZGMZZKVGDZM
Date   Source Headline
29th Apr 20247:00 amRNSFinal Results
26th Apr 20247:00 amRNSQ1 2024 Production Results
15th Feb 20241:00 pmRNSSale of 3rd Tranche of Exempt Offer Bond Programme
1st Feb 20247:00 amRNSFeasibility Study Update & Bond Programme
12th Jan 20247:00 amRNSQ4 2023 Production Results
22nd Dec 20237:00 amRNSTrading Update
30th Nov 20237:00 amRNSTotal Voting Rights
22nd Nov 20237:00 amRNSHolding(s) in Company
21st Nov 202312:17 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSIssue of Equity
1st Nov 20235:08 pmRNSResult of AGM
17th Oct 20237:00 amRNSExempt Offer Bond Programme - Second Tranche Sale
10th Oct 202312:53 pmRNSExisting Operation Q3 Production Results
6th Oct 20237:00 amRNSNotice of AGM
19th Sep 20237:00 amRNSExempt Offer Bond Programme - Second Tranche
12th Sep 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSGrant of Share Options
11th Sep 20237:00 amRNSHalf-year Report
21st Aug 20237:00 amRNSTrading Update
27th Jul 20239:00 amRNSLaunch of Bond Programme /Listing of First Tranche
19th Jul 20237:00 amRNSInvestor Presentation via Investor Meet Company
17th Jul 20237:00 amRNSExisting Operation H1 Production Results
3rd May 20237:00 amRNSInvestor Presentation via Investor Meet Company
2nd May 20232:25 pmRNSDirectors Share Purchase
2nd May 20232:20 pmRNSFull Updated Ore-Body 1 Mineral Resource Estimate
28th Apr 20237:00 amRNS2022 Final Results and Updated Ore-Body 1 MRE
30th Jan 20237:00 amRNSTrading & Operational Update and Grant Funding
20th Dec 20222:05 pmRNSSecond Price Monitoring Extn
20th Dec 20222:00 pmRNSPrice Monitoring Extension
20th Dec 20227:00 amRNSBalasausqandiq Feasibility Study Update
7th Dec 20227:00 amRNSFeasibility Study: Drilling Programme Completes
28th Nov 20224:41 pmRNSSecond Price Monitoring Extn
28th Nov 20224:36 pmRNSPrice Monitoring Extension
28th Nov 20222:05 pmRNSSecond Price Monitoring Extn
28th Nov 20222:00 pmRNSPrice Monitoring Extension
10th Nov 20223:43 pmRNSResult of AGM
13th Oct 20227:00 amRNSNotice of AGM
27th Sep 20226:00 pmRNSHolding(s) in Company
22nd Sep 20227:00 amRNSGrant of Options
15th Sep 20225:15 pmRNSResult of PrimaryBid Offer
15th Sep 202212:20 pmRNSResult of Placing and Subscriptions
15th Sep 20227:02 amRNSPrimaryBid Offer
15th Sep 20227:01 amRNSProposed Placing
15th Sep 20227:00 amRNSInterim Results
1st Jul 20227:38 amRNSBalasausqandiq Feasibility Study Update
1st Jul 20227:00 amRNSBalasausqandiq Feasibility Study Update
29th Jun 20227:00 amRNSGrant of Options
29th Apr 20227:00 amRNSFinal Results
5th Apr 20224:41 pmRNSSecond Price Monitoring Extn
5th Apr 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.